Armergometry to Improve Mobility in MS
Armergometry to Improve Mobility in Chronic Progressive Multiple Sclerosis
What it found
A paper reports the results; we have not read it yet. See Papers below.
What was tested
Treatment tested
- arm ergometry
What it measured
Main measures
6 minute walking test
6 min.
Walking and mobility
Other measures (5)
accelerometry
7 days
Walking and mobilityverbal learning and memory
30 minutes
Thinking and memorypeak oxygene uptake
20 minutes
brain atrophy
3 months
Brain volume lossBrain derived neurotrophic factor
3 months change
Who could take part
Progressive MS · 18 to 60
Show the full criteria
Inclusion criteria
* proven multiple sclerosis * stable disease * EDD 4,0-6,5 * being able to perform arm ergometry
Exclusion criteria
* relapse situation * cognitive deficit unable to understand study * cardivascular disease * contraindication for MRI
As registered. Criteria can change, so ask the trial team or your neurologist.
About this trial
In the sponsor's words
Chronic progressive multiple sclerosis patients will be randomised to home-based arm ergometry training for 12 weeks or a waitlist control group which will have access to the treatment after 12 weeks when primary endpoint assessment has been obtained. Assessments include clinical outcomes and questionnaires as well MRI imaging and transcranial magnetic stimulation paradigms. Primary endpoint will be the 6 minute walking test at week 12.
Papers
Loading reviews and guidelines…
History
Started
May 2017
Main results due
Jul 2018
Finished
Dec 2018